Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.30 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9610783 | 0.89 | NPSR1 (0.34) | NPSR1L3MBTL1MEN1KMT2A | |
| SCHEMBL9612214 | 0.89 | — | — | |
| SCHEMBL9610788 | 0.88 | NPSR1 (0.32) | NPSR1L3MBTL1PABPC1CTDSP1 | |
| SCHEMBL16807919 | 0.84 | — | — | |
| SCHEMBL9610786 | 0.80 | PABPC1 (0.42) | PABPC1CTDSP1 | |
| SCHEMBL9610771 | 0.79 | HSD11B1 (0.33) | MEN1KMT2APABPC1CTDSP1 | |
| SCHEMBL9610785 | 0.79 | PABPC1 (0.40) | PABPC1CTDSP1 | |
| SCHEMBL9612208 | 0.78 | CA2 (0.35) | NPSR1L3MBTL1MEN1KMT2A | |
| SCHEMBL9612210 | 0.78 | L3MBTL1 (0.30) | L3MBTL1 | |
| SCHEMBL9610781 | 0.76 | NPSR1 (0.34) | NPSR1L3MBTL1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8420294-B2 | Salt and photoresist composition comprising the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-04-16 | — | — | US | disclosed |
| US-20120135351-A1 | SALT AND PHOTORESIST COMPOSITION COMPRISING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120135351-A1 | SALT AND PHOTORESIST COMPOSITION COMPRISING THE SAME | C1R, AFF1, C1S | NPSR1 360/4885L3MBTL1 2547/4885MEN1 825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.